S1P Therapeutics

Cultivating a small-molecule therapy that can modulate immune signaling pathways is the goal of S1P Therapeutics. Their aim is to treat chronic kidney disease and other serious conditions, and they’ll be pursuing this goal as they grow through the Spring 2026 Cohort.